Reports - Targeted Therapeutics Market
HealthcareTargeted Therapeutics Market
Targeted Therapeutics Market Valuation and Future Projections to 2035 by Type (Monoclonal Antibodies, Small Molecules) by Application (Breast Cancer, Colorectal Cancer, Lung Cancer, Multiple Sclerosis, Renal Cancer, Other Applications) by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Targeted Therapeutics Market - Segment Analysis
1. Overview
2. Global Targeted Therapeutics Market, 2021 - 2035 (USD Million)
3. Global Targeted Therapeutics Market - by Type
3.1. By Monoclonal Antibodies
3.2. By Small Molecules
4. Global Targeted Therapeutics Market - by Application
4.1. By Breast Cancer
4.2. By Colorectal Cancer
4.3. By Lung Cancer
4.4. By Multiple Sclerosis
4.5. By Renal Cancer
4.6. By Other Applications
5. Global Targeted Therapeutics Market - by Distribution Channel
5.1. By Hospital Pharmacies
5.2. By Retail Pharmacies
5.3. By Online Pharmacies
6. Global Targeted Therapeutics Market - by region
6.1. North America
6.2. Europe
6.3. Asia Pacific
6.4. Latin America
6.5. Middle East & Africa
7. Market comparative analysis
Chapter 4 North America Targeted Therapeutics Market - Segment Analysis
1. Overview
2. North America Targeted Therapeutics Market, 2021 - 2035 (USD Million)
3. North America Targeted Therapeutics Market - by Type
3.1. By Monoclonal Antibodies
3.2. By Small Molecules
4. North America Targeted Therapeutics Market - by Application
4.1. By Breast Cancer
4.2. By Colorectal Cancer
4.3. By Lung Cancer
4.4. By Multiple Sclerosis
4.5. By Renal Cancer
4.6. By Other Applications
5. North America Targeted Therapeutics Market - by Distribution Channel
5.1. By Hospital Pharmacies
5.2. By Retail Pharmacies
5.3. By Online Pharmacies
Chapter 5 Europe Targeted Therapeutics Market - Segment Analysis
1. Overview
2. Europe Targeted Therapeutics Market, 2021 - 2035 (USD Million)
3. Europe Targeted Therapeutics Market - by Type
3.1. By Monoclonal Antibodies
3.2. By Small Molecules
4. Europe Targeted Therapeutics Market - by Application
4.1. By Breast Cancer
4.2. By Colorectal Cancer
4.3. By Lung Cancer
4.4. By Multiple Sclerosis
4.5. By Renal Cancer
4.6. By Other Applications
5. Europe Targeted Therapeutics Market - by Distribution Channel
5.1. By Hospital Pharmacies
5.2. By Retail Pharmacies
5.3. By Online Pharmacies
Chapter 6 Asia Pacific Targeted Therapeutics Market - Segment Analysis
1. Overview
2. Asia Pacific Targeted Therapeutics Market, 2021 - 2035 (USD Million)
3. Asia Pacific Targeted Therapeutics Market - by Type
3.1. By Monoclonal Antibodies
3.2. By Small Molecules
4. Asia Pacific Targeted Therapeutics Market - by Application
4.1. By Breast Cancer
4.2. By Colorectal Cancer
4.3. By Lung Cancer
4.4. By Multiple Sclerosis
4.5. By Renal Cancer
4.6. By Other Applications
5. Asia Pacific Targeted Therapeutics Market - by Distribution Channel
5.1. By Hospital Pharmacies
5.2. By Retail Pharmacies
5.3. By Online Pharmacies
Chapter 7 Latin America Targeted Therapeutics Market - Segment Analysis
1. Overview
2. Latin America Targeted Therapeutics Market, 2021 - 2035 (USD Million)
3. Latin America Targeted Therapeutics Market - by Type
3.1. By Monoclonal Antibodies
3.2. By Small Molecules
4. Latin America Targeted Therapeutics Market - by Application
4.1. By Breast Cancer
4.2. By Colorectal Cancer
4.3. By Lung Cancer
4.4. By Multiple Sclerosis
4.5. By Renal Cancer
4.6. By Other Applications
5. Latin America Targeted Therapeutics Market - by Distribution Channel
5.1. By Hospital Pharmacies
5.2. By Retail Pharmacies
5.3. By Online Pharmacies
Chapter 8 Middle East & Africa Targeted Therapeutics Market - Segment Analysis
1. Overview
2. Middle East & Africa Targeted Therapeutics Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Targeted Therapeutics Market - by Type
3.1. By Monoclonal Antibodies
3.2. By Small Molecules
4. Middle East & Africa Targeted Therapeutics Market - by Application
4.1. By Breast Cancer
4.2. By Colorectal Cancer
4.3. By Lung Cancer
4.4. By Multiple Sclerosis
4.5. By Renal Cancer
4.6. By Other Applications
5. Middle East & Africa Targeted Therapeutics Market - by Distribution Channel
5.1. By Hospital Pharmacies
5.2. By Retail Pharmacies
5.3. By Online Pharmacies
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. Agenus Inc. (U.S.)
2. Aurinia Pharmaceuticals Inc. (Canada)
3. Celdara Medical LLC (U.S.)
4. Pfizer Inc. (U.S.)
5. Gilead Sciences Inc. (U.S.)
6. Nektar Therapeutics Inc. (U.S.)
7. F. Hoffmann-La Roche & Co. (Switzerland)
8. Amgen Inc. (U.S.)
9. Serena Therapeutics Inc. (U.S.)
10. AstraZeneca PLC (UK)
11. Arcus Biosciences Inc. (U.S.)
12. Genentech Inc. (U.S.)
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By